Our company sells research products exclusively to qualified researchers and laboratories for in vitro and laboratory use
It is a dietary supplement, not a medication, and has not been reviewed by the FDA for safety or effectiveness
Chronic Disease Management: Increased use of GLP-1 medications may reduce the incidence of diabetes-related hospitalizations by 10%15% and cardiovascular events by up to 20%, improving long-term population health outcomes
Despite growing awareness of GLP-1 medications, obesity is still often misunderstood
Opportunities for Retail With the shift in consumer behaviors due to GLP-1 drugs, there has been a significant impact on purchasing patterns, thus influencing retailers
Problema: al suspender el frmaco, gran parte del peso perdido se recupera : aproximadamente dos tercios del peso perdido se recupera en 1 ao, lo que sugiere tratamiento crnico para mantener beneficios (4, 5)